Navigation Links
XTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals
Date:3/20/2008

VALLEY COTTAGE, N.Y., March 20 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB, TASE: XTL) announced the licensing of its pre-clinical program in Hepatitis C focused on the NS5A target (the "Program") to San-Francisco based Presidio Pharmaceuticals, Inc. Presidio is a private biotechnology company focused on the development and commercialization of anti-viral therapeutics and is backed by some of the most prominent investors in the biotechnology sector, including Panorama Capital, Bay City Capital, Baker Brothers Investments, and Ventures West. Presidio's scientific team is headed by Dr. Richard Colonno, who until recently was Vice President of Infectious Disease Drug Discovery at Bristol-Myers Squibb, where he was responsible for Bristol-Myers Squibb's antiviral drug discovery efforts, including their Hepatitis C and B and HIV programs.

Under the license agreement, Presidio becomes responsible for all further development and commercialization activities and costs relating to the Program. XTL will receive an upfront payment of $4 million, and up to an additional $104 million upon reaching certain development and commercialization milestones. In addition, XTL will receive a royalty on direct product sales by Presidio, and a percentage of Presidio's income if the Program is sublicensed by Presidio to a third party.

Ram Waisbourd, Vice President of Business Development of XTL, commented: "We have great confidence in Presidio's ability to move the Program forward rapidly. We believe that Presidio has a dynamic and experienced management team, and a solid scientific team headed by Dr. Richard Colonno -- who was a major contributor to the discovery and advancement of several antiviral drug candidates into clini
'/>"/>

SOURCE XTL Biopharmaceuticals Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
2. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
3. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
4. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
5. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
6. Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG
7. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
8. Morria Biopharmaceuticals Plc Announces Appointment of Dr. Rosemary Mazanet as Interim Chief Executive Officer
9. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
10. Morria Biopharmaceuticals Plc Appoints Dr. Johnson Lau and Dr. David Sidransky to Board of Directors
11. XTL Biopharmaceuticals Ltd. AGM / EGM Postponed Until October 2, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... Sunset, LA (PRWEB) July 21, 2014 ... poor sleep quality are closely correlated with depression. ... Institutes of Health: "About three quarters of ... present in about 40% of young depressed adults ... in females. The symptoms cause huge distress, have ...
(Date:7/18/2014)... 18, 2014  Neogen Corporation (Nasdaq: NEOG ... chief operating officer and president, has resigned, effective July ... a consultant going forward on special projects. His resignation ... in this position since September 2013. On an interim ... Herbert , who has been Neogen,s chief executive officer ...
(Date:7/18/2014)... & Cambridge, MA (PRWEB) July 18, 2014 ... headquartered in Budapest with US offices in Cambridge, ... - a combination Assay and Software product that ... for use on the Illumina® MiSeq sequencing platform. ... collaboration with The Children’s Hospital of Philadelphia (CHOP) ...
(Date:7/18/2014)... 18, 2014 Provia Laboratories announces the ... Advisory Board. Dr. Vaught has worked in the ... years. As one of the founding members of ... Repositories - in 1999, he served as its second ... , In 2005, Dr. Vaught began working with the ...
Breaking Biology Technology:Open Label Data on Enhanced Sleep Released by JayMac Pharmaceuticals, LLC 2Open Label Data on Enhanced Sleep Released by JayMac Pharmaceuticals, LLC 3Omixon Launches Holotype HLA for NGS-based HLA Genotyping 2Omixon Launches Holotype HLA for NGS-based HLA Genotyping 3Dr. Jim Vaught, Ph.D., Former Chief of BBRB, Joins Provia Laboratories as Advisory Board Member 2Dr. Jim Vaught, Ph.D., Former Chief of BBRB, Joins Provia Laboratories as Advisory Board Member 3
... day that a research scientist and university professor gets to see ... few months, Richard W. Siegel will get to watch his name ... a new title that seems light years away from laboratory benches ... MAX," has been a three-year labor of love for Siegel. From ...
... IN KEY GLOBAL MARKETS, RANCHO CORDOVA, Calif., ... a leading supplier of innovative products and,services that ... it has signed,a distribution agreement with Celling Technologies ... stem cells from bone,marrow. The distribution rights are ...
... Sept. 9 For the second consecutive,year, MedNet ... study management systems, has been recognized by,Inc. magazine ... private,organizations. With consistently strong growth over the past ... in the Twin Cities,metro area, and fifth among ...
Cached Biology Technology:Professor-turned-producer learns the movie biz 2Professor-turned-producer learns the movie biz 3Professor-turned-producer learns the movie biz 4Professor-turned-producer learns the movie biz 5ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device 2ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device 3ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device 4MedNet Solutions Again Recognized as one of the Fastest Growing US Companies 2
(Date:7/21/2014)... streamlined and simplified a process that uses extracts from ... levels of harmful bacteria by 90% to 99%. The ... throughout many countries of Africa, Asia, and Latin America. ... Current Protocols in Microbiology review, is low-cost and ... extreme poverty in developing countries who are presently drinking ...
(Date:7/21/2014)... climate change, due to greenhouse gasses emitted by livestock. ... rise and that beef cattle are responsible for far ... It is published by Climactic Change . ... comes to climate change. It is released by vehicles, ... of greenhouse gas totals. But methane and nitrous oxide ...
(Date:7/21/2014)... of high-fat foods cause you to lose your sense ... University neuroscientists says so, and it has researchers taking ... a whole range of human functions that were not ... "This opens up a lot of possibilities for obesity ... who led the study examining how high-fat foods impacted ...
Breaking Biology News(10 mins):Climate: Meat turns up the heat 2New research links bad diet to loss of smell 2
... Science Research Conference on focuses on recent advances in ... transcriptional regulators, currently numbering 17, and will also include ... Held twice previously, this FASEB Conference is the ... The major themes of the conference will be the ...
... medicine? The media are invited to register now for ... Clinical Genetics Meeting, March 25-29, 2014 at the Nashville ... Sequencing to Cancer Genetics, the focus of the ACMG ... genomics in healthcare, showcasing the latest breakthroughs in genetics ...
... European consortium of epilepsy researchers has reported the discovery ... Using a novel combination of technologies, including trio exome ... tiny larvae of zebrafish, the EuroEPINOMICS RES consortium found ... a subset of epilepsy patients with symptoms similar to ...
Cached Biology News:Complimentary press registration now open for ACMG 2014 Annual Clinical Genetics Meeting 2European epilepsy consortium identifies new gene for severe childhood epilepsy 2European epilepsy consortium identifies new gene for severe childhood epilepsy 3European epilepsy consortium identifies new gene for severe childhood epilepsy 4
Contains L-glutamine...
... (PEBP) does not share significant homology ... PEBP is expressed in the central ... and stomach. One important role ... inhibitory activity against several serine proteases ...
...
Highly sensive assay for detecting apoptosis in living cells. See detailed descriptions above in K250-25....
Biology Products: